These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 34829907)

  • 1. Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson's Disease.
    Ko CJ; Gao SL; Lin TK; Chu PY; Lin HY
    Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron Metabolism in Ferroptosis.
    Chen X; Yu C; Kang R; Tang D
    Front Cell Dev Biol; 2020; 8():590226. PubMed ID: 33117818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOX4 exacerbates Parkinson's disease pathology by promoting neuronal ferroptosis and neuroinflammation.
    Lin Z; Ying C; Si X; Xue N; Liu Y; Zheng R; Chen Y; Pu J; Zhang B
    Neural Regen Res; 2025 Jul; 20(7):2038-2052. PubMed ID: 38993139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis and its potential role in the physiopathology of Parkinson's Disease.
    Mahoney-Sánchez L; Bouchaoui H; Ayton S; Devos D; Duce JA; Devedjian JC
    Prog Neurobiol; 2021 Jan; 196():101890. PubMed ID: 32726602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ferroptosis underlies EGCG mediated protection against Parkinson's disease in a Drosophila model.
    Xia Y; Wang H; Xie Z; Liu ZH; Wang HL
    Free Radic Biol Med; 2024 Feb; 211():63-76. PubMed ID: 38092273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial CR3 promotes neuron ferroptosis via NOX2-mediated iron deposition in rotenone-induced experimental models of Parkinson's disease.
    Wang Q; Liu J; Zhang Y; Li Z; Zhao Z; Jiang W; Zhao J; Hou L; Wang Q
    Redox Biol; 2024 Nov; 77():103369. PubMed ID: 39357423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of Iron Chelators in the Treatment of Parkinson's Disease.
    Zeng X; An H; Yu F; Wang K; Zheng L; Zhou W; Bao Y; Yang J; Shen N; Huang D
    Neurochem Res; 2021 May; 46(5):1239-1251. PubMed ID: 33646533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACSL4 and the lipoxygenases 15/15B are pivotal for ferroptosis induced by iron and PUFA dyshomeostasis in dopaminergic neurons.
    Bouchaoui H; Mahoney-Sanchez L; Garçon G; Berdeaux O; Alleman LY; Devos D; Duce JA; Devedjian JC
    Free Radic Biol Med; 2023 Feb; 195():145-157. PubMed ID: 36581060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis: A potential therapeutic target for neurodegenerative diseases.
    Vitalakumar D; Sharma A; Flora SJS
    J Biochem Mol Toxicol; 2021 Aug; 35(8):e22830. PubMed ID: 34047408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis in Parkinson's disease: glia-neuron crosstalk.
    Wang ZL; Yuan L; Li W; Li JY
    Trends Mol Med; 2022 Apr; 28(4):258-269. PubMed ID: 35260343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis.
    Jiang X; Wu K; Ye XY; Xie T; Zhang P; Blass BE; Bai R
    Med Res Rev; 2023 Jul; 43(4):872-896. PubMed ID: 36924451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron toxicity, ferroptosis and microbiota in Parkinson's disease: Implications for novel targets.
    Carvalho FV; Landis HE; Getachew B; Silva VDA; Ribeiro PR; Aschner M; Tizabi Y
    Adv Neurotoxicol; 2024; 11():105-132. PubMed ID: 38770370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research progress in the molecular mechanism of ferroptosis in Parkinson's disease and regulation by natural plant products.
    Yang K; Zeng L; Zeng J; Deng Y; Wang S; Xu H; He Q; Yuan M; Luo Y; Ge A; Ge J
    Ageing Res Rev; 2023 Nov; 91():102063. PubMed ID: 37673132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ferroptosis pathways in neuroinflammation and neurological disorders: From pathogenesis to treatment.
    Mohan S; Alhazmi HA; Hassani R; Khuwaja G; Maheshkumar VP; Aldahish A; Chidambaram K
    Heliyon; 2024 Feb; 10(3):e24786. PubMed ID: 38314277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease Therapy.
    Lei L; Yuan J; Dai Z; Xiang S; Tu Q; Cui X; Zhai S; Chen X; He Z; Fang B; Xu Z; Yu H; Tang L; Zhang C
    Adv Mater; 2024 Oct; 36(41):e2409329. PubMed ID: 39221531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Insights on Ferroptosis in Parkinson's disease.
    Thapa K; Khan H; Kanojia N; Singh TG; Kaur A; Kaur G
    Eur J Pharmacol; 2022 Sep; 930():175133. PubMed ID: 35792170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis as a New Mechanism in Parkinson's Disease Therapy Using Traditional Chinese Medicine.
    Wu L; Liu M; Liang J; Li N; Yang D; Cai J; Zhang Y; He Y; Chen Z; Ma T
    Front Pharmacol; 2021; 12():659584. PubMed ID: 34163356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Ferroptosis Pathways: A Novel Strategy for Cancer Therapy.
    Maru D; Hothi A; Bagariya C; Kumar A
    Curr Cancer Drug Targets; 2022; 22(3):234-244. PubMed ID: 35152865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid Metabolism in Ferroptosis.
    Lin Z; Liu J; Kang R; Yang M; Tang D
    Adv Biol (Weinh); 2021 Aug; 5(8):e2100396. PubMed ID: 34015188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Target for Prevention and Treatment of Neuroinflammation: Microglia Iron Accumulation and Ferroptosis.
    Liu S; Gao X; Zhou S
    ASN Neuro; 2022; 14():17590914221133236. PubMed ID: 36285433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.